Scarica l'app Stockscreener
2.30
1.29%
-0.03
Dopo l'orario di chiusura:
2.35
0.05
+2.17%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché INBS Giù?
Forum
Previsione
Frazionamento azionario
Intelligent Bio Solutions Inc Borsa (INBS) Ultime notizie
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Share Price, INBS Stock News, INBS Share Price & Updates - Kalkine
Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings - TradingView
INBS Q1 2025 Earnings: EPS Misses Estimates as Company Reports No RevenueProduct Revenue Analysis - newsline.com
INBS Q1 2025 Earnings: Earnings Miss Widens as Losses DeepenDividend Cut Risk - newsline.com
Intelligent Bio Solutions (INBS) Holds Near Support Amid Quiet Trading SessionMACD Signal Stocks - newsline.com
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference Over June 16-18 - 富途牛牛
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - marketscreener.com
Vegas microcap conference adds Intelligent Bio Solutions to lineup - Stock Titan
Intelligent Bio Solutions (INBS) Launches Study for Drug Screeni - GuruFocus
Intelligent Bio Solutions Launches Multi-Site Study for FDA 510(k) Clearance of Fingerprint Drug Screening System 1 - Minichart
Intelligent Bio Solutions Launches FDA Study for Codeine Test - TipRanks
Intelligent Bio Solutions starts FDA study for fingerprint drug test - Investing.com
Intelligent begins multi-site study to support FDA 510(k) for codeine screening - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study - Stock Titan
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission - The Manila Times
Fingerprint drug test put in workers' hands in new U.S. study - Stock Titan
INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Stock Declines 3.5%Surprise Factor Analysis - newsline.com
Intelligent Bio Solutions (INBS) Edges Higher: Testing Key Resistance at $2.70Fundamental Weighted - newsline.com
INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not Reported, Stock Rises 2.19%Earnings Weakness Phase - The Legal Advocate
Intelligent Bio Solutions (INBS) Climbs 4.4% as Shares Test Key Resistance Near $2.71Delta Hedging - newsline.com
INBS Q1 2025 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentShort-Term Outlook - newsline.com
Intelligent Bio Solutions (INBS) Surges 7% as Shares Rebound from Support LevelIntraday Trade Ideas - The Legal Advocate
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider Loss Than Expected Weighs on SharesInstitutional Grade Picks - Newser
Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider-Than-Expected Loss Amid Continued Pre-Revenue StageTrending Entry Points - Newser
INBS|Intelligent Bio Solutions Inc|Price:2.530|Chg%:-0.10 - TradingKey
Intelligent Bio Solutions Company Profile & Introduction - Moomoo
Intelligent Bio Solutions 3Q Loss $2.87M >INBS - Moomoo
INBS - Finviz
[SCHEDULE 13G] INTELLIGENT BIO SOLUTIONS INC. Passive Investment Disclosure (>5%) - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Intelligent Bio Solutions (INBS) Undervalued After Q3 FY2026 - GuruFocus
Intelligent Bio Solutions (NASDAQ: INBS) grows Q3 revenue 46% with margins above 50% - Stock Titan
Intelligent Bio Reports Q3 Revenue Up 46%, Gross Margin Over 50% as Cartridge Sales Surge - TradingView
Intelligent Bio Solutions Inc. Q3 2026 10-Q Filing: Financial Statements, Reverse Stock Split, and Company Overview - Minichart
Intelligent Bio Solutions 3Q Loss/Shr $1.80 >INBS - Moomoo
Intelligent Bio Solutions Releases Q3 2026 Financial Results - AlphaStreet
Intelligent Bio Solutions Reports 46% Revenue Growth in Q3 FY202 - GuruFocus
Finger-scan drug test maker tops 50% margins as sales jump 46% - Stock Titan
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50% - TradingView
INTELLIGENT BIO SOLUTIONS INC. 3Q 2026: Revenue $1.06M, Net loss $(2.86M) — 10-Q Summary - TradingView
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year - marketscreener.com
Intelligent Bio Solutions (NASDAQ: INBS) boosts revenue but warns on going concern - Stock Titan
Intelligent Bio Solutions Inc. Reports Unaudited Impairment of Long-Lived Assets for the Third Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
INBS Q3'26 Earnings: EPS estimate is 1.40 USD - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Intelligent Bio Solutions Inc (STU:12Q0) Stock Price & 30 Year Financial Data - GuruFocus
How Intelligent (INBS) is reshaping its industry (Trend Weakens) 2026-05-08Gap Down Stocks - newser.com
The moat Intelligent (INBS) is building for long term dominance (Breakdown Watch) 2026-05-05Top Breakouts - newser.com
1.21%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):